03 July 2026

Samvel’s condition has stabilized

At the moment, Samvel’s condition is stable. We learned from his doctors that, as originally planned, he first received Octagam as the primary treatment prescribed when ITP was initially identified.

However, after some time, when his platelet count began to drop again, the doctors changed the treatment approach and moved to a second-line therapy with Revolade. Samvel is now taking it regularly, and as a result, his condition remains stable while he continues to stay under medical supervision.